Abstract:Vitamin D deficiency and obesity are two public health problems extensively exacerbated over the last years. Among the several mechanisms proposed to account for the complex interplay between vitamin D and obesity, one that has gained particular attention is related to the emerging role of obesity-related changes in gut microbiota and gut-derived metabolites, such as Trimethylamine-N-oxide (TMAO). Vitamin D deficiency and high circulating TMAO levels are associated with body weight and the severity of non-alcoholic fatty liver disease (NAFLD). Considering the link of obesity with vitamin D on the one hand and obesity with TMAO on the other hand, and the central role of the liver in both the vitamin D and TMAO metabolism, the aim of this cross-sectional observational study was first, to confirm the possible inverse association between vitamin D and TMAO across different body mass index (BMI) classes and second, to investigate if this association could be influenced by the presence of NAFLD. One hundred and four adult subjects (50 males and 54 females; 35.38 ± 7.49 years) were enrolled. The fatty liver index (FLI) was used as a proxy for the diagnosis of NAFLD. Vitamin D deficiency was found in 65 participants (62.5%), while 33 subjects (31.7%) had insufficient levels, and the remaining subjects had sufficient levels of vitamin D. Subjects with both vitamin D deficiency and FLI-NAFLD had the highest TMAO levels (p < 0.001). By stratifying the sample population according to the BMI classes, vitamin D levels decreased significantly along with the increase of plasma TMAO concentrations, with the lowest vitamin D levels and highest TMAO, respectively, in class III obesity. Vitamin D levels showed significant opposite associations with circulating levels of TMAO (r = −0.588, p < 0.001), but this association was no longer significant after the adjustment for FLI values. The highest values of TMAO were significantly associated with the severity of obesity (OR 7.92; p < 0.001), deficiency of vitamin D (OR 1.62; p < 0.001), and FLI-NAFLD (OR 3.79; p < 0.001). The most sensitive and specific cut-off for vitamin D to predict the circulating levels of TMAO was ≤19.83 ng/mL (p < 0.001). In conclusion, our study suggests that high TMAO levels are associated with vitamin D deficiency and NAFLD. Further studies are required to investigate if there is a causality link or whether all of them are simply the consequence of obesity.

Unraveling the complex interplay between obesity and vitamin D metabolism

Ultra-high-performance Liquid Chromatography-Tandem Mass Spectrometry Analysis of Serum Metabolomic Characteristics in People with Different Vitamin D Levels

The Relationship between Body Compositions and Serum Vitamin D Levels in Obese Adolescents

The Status of Vitamin D in Obese Adults in Southern Morocco: a Cross-Sectional Study

Relationship between Obesity and Serum Vitamin D Levels in Young Women

Vitamin D and obesity: current perspectives and future directions

Novel Insight Into the Relationship of Vitamin D Hydroxylase and Vitamin D With Obesity in Patients With Type 2 Diabetes Mellitus

Evaluating a novel method for vitamin A analysis in an observational study of the UAE's obese population

Effects of high fat diet-induced obesity on vitamin D metabolism and tissue distribution in vitamin D deficient or supplemented mice

The association between body mass index elevation and differentiation in vitamin D receptor gene expression, genetic polymorphism, and oxidative stress in adult Egyptian individuals

The impact of vitamin D status on lipid profiles and atherogenic dyslipidemia markers in children and adolescents with obesity

biochemical study of angiotensin II, electrolytes and vitamin D in obese patients

Metabolomics Profiling of Vitamin D Status in Relation to Dyslipidemia

Effects of Vitamin D Supplementation on General and Central Obesity: Results from 20 Randomized Controlled Trials Involving Apparently Healthy Populations

A New Light on Vitamin D in Obesity: A Novel Association with Trimethylamine-N-Oxide (TMAO)

Dynamic Evaluation of Vitamin D Metabolism in Post-Bariatric Patients

Adiposity, vitamin D requirements, and clinical implications for obesity-related metabolic abnormalities

Vitamin D status and obesity markers in older adults: results from West China Health and Aging Trends study

Vitamin D deficiency in adolescents with obesity - Altered metabolism or environmental factors?

The link between vitamin D, chemerin and metabolic profile in overweight and obese children - preliminary results

Vitamin D Status, Cardiometabolic, Liver, and Mental Health Status in Obese Youth Attending a Pediatric Weight Management Center